Financhill
Sell
10

SMG Quote, Financials, Valuation and Earnings

Last price:
$57.95
Seasonality move :
-5.07%
Day range:
$54.20 - $55.38
52-week range:
$53.37 - $93.90
Dividend yield:
4.82%
P/E ratio:
--
P/S ratio:
0.88x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
1.2M
1-year change:
-23.69%
Market cap:
$3.1B
Revenue:
$3.6B
EPS (TTM):
-$0.48

Analysts' Opinion

  • Consensus Rating
    The Scotts Miracle Gro has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 5 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $78.88, The Scotts Miracle Gro has an estimated upside of 44.01% from its current price of $54.77.
  • Price Target Downside
    According to analysts, the lowest downside price target is $70.00 representing 100% downside risk from its current price of $54.77.

Fair Value

  • According to the consensus of 10 analysts, The Scotts Miracle Gro has 44.01% upside to fair value with a price target of $78.88 per share.

SMG vs. S&P 500

  • Over the past 5 trading days, The Scotts Miracle Gro has underperformed the S&P 500 by -2.42% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • The Scotts Miracle Gro does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • The Scotts Miracle Gro has grown year-over-year revenues for 3 quarters straight. In the most recent quarter The Scotts Miracle Gro reported revenues of $416.8M.

Earnings Growth

  • The Scotts Miracle Gro has grown year-over-year earnings for 2 quarters straight. In the most recent quarter The Scotts Miracle Gro reported earnings per share of -$1.21.
Enterprise value:
5.8B
EV / Invested capital:
--
Price / LTM sales:
0.88x
EV / EBIT:
40.34x
EV / Revenue:
1.64x
PEG ratio (5yr expected):
-0.16x
EV / Free cash flow:
11.90x
Price / Operating cash flow:
6.42x
Enterprise value / EBITDA:
26.04x
Gross Profit (TTM):
$883.1M
Return On Assets:
-0.7%
Net Income Margin (TTM):
-0.67%
Return On Equity:
--
Return On Invested Capital:
-1.03%
Operating Margin:
-8.28%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $3.9B $3.4B $3.6B $410.4M $416.8M
Gross Profit $849.9M $623.8M $883.1M $62.2M $94.8M
Operating Income $259.6M $85M $291.6M -$54.4M -$34.5M
EBITDA -$345.1M -$207.4M $223.9M -$51.3M -$43.3M
Diluted EPS -$8.21 -$7.04 -$0.48 -$1.42 -$1.21
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $1.7B $2.3B $2.3B $1.7B $1.3B
Total Assets $4B $5.2B $4.5B $3.7B $3.2B
Current Liabilities $1.1B $915.2M $931.7M $764.1M $683.8M
Total Liabilities $3.3B $4.4B $4.5B $4.1B $3.6B
Total Equity $679M $831.6M $59.5M -$385.4M -$479.5M
Total Debt $2.2B $3.2B $3.4B $3B $2.7B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $204.5M $619.4M $565.4M -$343.2M -$445.3M
Cash From Investing -$74M -$82.9M -$70.5M -$53.2M -$23.3M
Cash From Financing -$121.1M -$552.1M -$494.4M $374.2M $407.7M
Free Cash Flow $107.5M $518.3M $490M -$381.1M -$474.6M
SMG
Sector
Market Cap
$3.1B
$17.8M
Price % of 52-Week High
58.33%
60.85%
Dividend Yield
4.82%
0%
Shareholder Yield
4.01%
1.21%
1-Year Price Total Return
-23.69%
-13.51%
Beta (5-Year)
1.963
0.927
Dividend yield:
4.82%
Annualized payout:
$2.64
Payout ratio:
-640.59%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $56.49
200-day SMA
Sell
Level $71.05
Bollinger Bands (100)
Sell
Level 61.08 - 76.26
Chaikin Money Flow
Buy
Level 59.8M
20-day SMA
Sell
Level $59.16
Relative Strength Index (RSI14)
Sell
Level 29.68
ADX Line
Sell
Level 38.62
Williams %R
Buy
Level -84.8156
50-day SMA
Sell
Level $64.08
MACD (12, 26)
Sell
Level -2.31
25-day Aroon Oscillator
Sell
Level -60
On Balance Volume
Neutral
Level 58.1M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.5471)
Sell
CA Score (Annual)
Level (-2.6033)
Buy
Beneish M-Score (Annual)
Level (-4.0775)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (9.1623)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the us. The business consists of three reporting segments: us consumer, Hawthorne, and other. The us consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. us consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the us, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.

Stock Forecast FAQ

In the current month, SMG has received 5 Buy ratings 5 Hold ratings, and 0 Sell ratings. The SMG average analyst price target in the past 3 months is $78.88.

  • Where Will The Scotts Miracle Gro Stock Be In 1 Year?

    According to analysts, the consensus estimate is that The Scotts Miracle Gro share price will rise to $78.88 per share over the next 12 months.

  • What Do Analysts Say About The Scotts Miracle Gro?

    Analysts are divided on their view about The Scotts Miracle Gro share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Scotts Miracle Gro is a Sell and believe this share price will drop from its current level to $70.00.

  • What Is The Scotts Miracle Gro's Price Target?

    The price target for The Scotts Miracle Gro over the next 1-year time period is forecast to be $78.88 according to 10 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is SMG A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for The Scotts Miracle Gro is a Leans Bullish. 5 of 10 analysts rate the stock a Leans Bullish at this time.

  • How Can I Buy Shares Of SMG?

    You can purchase shares of The Scotts Miracle Gro via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Scotts Miracle Gro shares.

  • What Is The The Scotts Miracle Gro Share Price Today?

    The Scotts Miracle Gro was last trading at $57.95 per share. This represents the most recent stock quote for The Scotts Miracle Gro. Yesterday, The Scotts Miracle Gro closed at $54.77 per share.

  • How To Buy The Scotts Miracle Gro Stock Online?

    In order to purchase The Scotts Miracle Gro stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
GATE alert for Apr 2

Marblegate Acquisition [GATE] is up 86.64% over the past day.

Buy
52
NUTX alert for Apr 2

Nutex Health [NUTX] is up 5.41% over the past day.

Buy
75
CORT alert for Apr 2

Corcept Therapeutics [CORT] is down 8.84% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock